SJS Investment Consulting’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$171K Buy
2,963
+118
+4% +$6.78K 0.02% 177
2026
Q1
$173K Buy
2,845
+739
+35% +$43.1K 0.02% 160
2025
Q4
$114K Buy
2,106
+1,275
+153% +$61.3K 0.01% 190
2025
Q3
$37.5K Sell
831
-167
-17% -$7.8K 0.01% 410
2025
Q2
$46.2K Sell
998
-43
-4% -$2.11K 0.01% 194
2025
Q1
$63.5K Sell
1,041
-11
-1% -$641 0.01% 173
2024
Q4
$59.5K Buy
1,052
+47
+5% +$2.63K 0.01% 174
2024
Q3
$52K Buy
1,005
+175
+21% +$8.21K 0.01% 195
2024
Q2
$34.5K Sell
830
-22
-3% -$984 0.01% 209
2024
Q1
$46.2K Buy
852
+1
+0.1% +$51 0.01% 192
2023
Q4
$43.7K Buy
851
+7
+0.8% +$367 0.01% 177
2023
Q3
$49K Buy
844
+3
+0.4% +$184 0.01% 162
2023
Q2
$53.8K Buy
841
+48
+6% +$3.22K 0.01% 150
2023
Q1
$55K Sell
793
-100
-11% -$7.05K 0.02% 145
2022
Q4
$64.3K Buy
893
+106
+13% +$7.99K 0.02% 141
2022
Q3
$56K Buy
+787
New +$57.1K 0.02% 152
2022
Q1
$95K Buy
1,294
+62
+5% +$4.16K 0.03% 134
2021
Q4
$77K Buy
+1,232
New +$72.3K 0.02% 147

Other funds holding BMY

SJS Investment Consulting's BMY Position: Q2 2026 in Review

SJS Investment Consulting increased its Bristol-Myers Squibb (BMY) stake by 4.1% in Q2 2026, buying an estimated $6.78K and bringing the position to 2,963 shares worth $171K. The position accounts for 0.02% of the portfolio, ranked #177.

SJS Investment Consulting first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $173K in Q1 2026. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • SJS Investment Consulting held 2,963 shares of Bristol-Myers Squibb worth $171K as of Q2 2026.
  • SJS Investment Consulting bought 118 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.78K.
  • Bristol-Myers Squibb made up 0.02% of SJS Investment Consulting's portfolio in Q2 2026, its #177 holding.
  • SJS Investment Consulting first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
  • SJS Investment Consulting's Bristol-Myers Squibb position peaked at $173K in Q1 2026.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.